Trial of Pembrolizumab and Radiotherapy in Melanoma
Clinical trial NCT02562625 · TERMINATED
Trial details
- NCT number
- NCT02562625
- Sponsor
- Royal Marsden NHS Foundation Trust
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-11
- Primary completion
- 2020-03-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.